Obesity is termed as the pathology defined by excess body weight due to the increase in adipocytes. It can be visceral, close to the omentum, mesentery, and subcutaneous, accumulated in the hypodermis. It is a disease that entails metabolic, respiratory, locomotor, and cardiovascular problems, type II diabetes, cancer, and even mental problems. Established by the Body Mass Index (BMI) and defined from the relationship between weight (kg) and height (m) of individuals. In numerical terms, a person is considered obese when the BMI is equal to or greater than 30 kg/m. This retrospective study took into account the more than 30 years that the coordinator of this work has devoted to morbidly obese people and all his 47 years of experience in medicine. The first obese person of his career was 41 years old and weighed 210 kg. As soon as she arrived at the hospital, she said: “Doctor, I am here, because I need to enter a ‘workshop’, to repair my body”. From that moment on, the name “workshop” became part of a fantastic project with obese people called “Obese Workshop”. Over time, the number of patients with this comorbidity has only increased, reaching, once, the point of speaking to 325 interested parties in a single day and in the same hall. In order to achieve satisfactory results, we have established a number of tests, by which we could diagnose several reasons that cause obesity. We selected randomly 20 patients of both sexes, morbidly obese, operated in 2013. We do not take into account age, race, creed, or social status.
References
[1]
Lotufo, P.A. (1998) Early Mortality from Heart Disease in Brazil. Comparison with Other Countries. Arq Bras Cardiol, 70, 321-325. https://doi.org/10.1590/S0066-782X1998000500003
[2]
Monteiro, C.A., D’A Benicio, M.H., Conde, W.L. and Popkin, B.M. (2000) Shifting Obesity Trends in Brazil. European Journal of Clinical Nutrition, 4, 342-346. https://doi.org/10.1038/sj.ejcn.1600960
[3]
Austin, M.A. (1999) Epidemiology of Hypertriglyceridemia and Cardiovascular Disease. American Journal of Cardiology, 83, 13-16. https://doi.org/10.1016/S0002-9149(99)00209-X
[4]
Halpern, A. and Mancini, M.C. (2001) Obesidade. Revista Brasileira de Medicina do Esporte, 57-77.
[5]
Sasson, Z., Rasooly, Y., Bhesania, T. and Rasooly, I. (1993) Insulin Resistance is an Importante Determinant of Left Ventricular Mass in Obese. Circulation, 88, 1431-1436. https://doi.org/10.1161/01.CIR.88.4.1431
[6]
Benotti, P.N., Bistrian, B., Benotti, J.R., Blackburn, G. and Forse, R.A. (1992) Heart Disease and Hypertension in Severe Obesity: The Benefits of Weight Reduction. The American Journal of Clinical Nutrition, 55, 586-590. https://doi.org/10.1093/ajcn/55.2.586s
[7]
Hla, K.M., Young, T.B., Bidwell, T., Palta, M., Skatrud, J.B. and Dempsey, J. (1994) Sleep Apnea and Hypertension: A Population Based Study. Annals of Internal Medicine, 120, 382-388. https://doi.org/10.7326/0003-4819-120-5-199403010-00005
[8]
Maslowska, M.H., Sniderman, A.D., MacLean, L.D. and Cianflone, K. (1993) Regional Differences in Triacyglycerol Synthesis in Adipose Tissue. Journal of Lipid Research, 34, 219-228. https://doi.org/10.1016/S0022-2275(20)40749-7
[9]
Montague, C.T., Prins, J.B., Sanders, L., Zhang, J., Sewter, C.P., Digby, J., et al. (1998) Deprot-Related Gene Expression in Human Subcutaneous and Omental Adipocytes. Diabetes, 47, 1384-1391. https://doi.org/10.2337/diabetes.47.9.1384
[10]
Ferreira, S.R.G., Franco, L.J., Gimeno, S.G.A., Iochida, L.C. and Iunes, M. (1997) Is Insulin or Its Precursor. Independently Associated to Hypertension? An Epidemiological Study in Japanese-Brazilians. Hypertension, 30, 641-645. https://doi.org/10.1161/01.HYP.30.3.641
[11]
Rosenfeld, J. and Shohat, J. (1983) Obesity and Hypertension. In: Gross, F. and Strasser, T., Eds., Mild Hypertension: Recent Advances, New York, Raven Press, 197-208.
[12]
Dalsin, C., Schemes, C. and Pacheco, B. (2015) Women, Obesity and Fashion: A Case Study in the City of Carlos Barbosa, RS. https://www.efdeportes.com/efd204/mulher-obesidade-e-moda-um-estudo.htm
[13]
Dubois, J.C.L. (1978) Anorexia Nervosa in Men: Obsession with “Weith identity”. Some Nosological and Therapeutic Considerations. Annalés Médico Psychológiques, 136, 619-624.
[14]
Cercato, C., Mancini, M.C., Arguello, A.M.C., Passos, V.Q., Villares, S.M.F. and Halpern, A. (2004) Systemic Hypertension, Diabetes Mellitus, and Dislipidemia in Relation to Body Mass Index: Evaluation of a Brasilian Population. Revista do Hospital das Clínicas, 59, 113-118. https://doi.org/10.1590/S0041-87812004000300004
[15]
Kral, J.G. (1985) Morbid Obesity and Related Health Risks. Annals of Internal Medicine, 103, 1043-1047. https://doi.org/10.7326/0003-4819-103-6-1043
[16]
Stubbs, R.S. and Wickremesekera, S.K. (2002) Insulin Resistance in Severely Obese Links with Metabolic Co-Morbidities. Obesity Surgery, 12, 343-348. https://doi.org/10.1381/096089202321088110
[17]
Capella, J.F., Capella, R.F., Mandac, H. and Nath, P. (1991) Vertical Banded Gastroplasty Gastric Bypass: Preliminary Report. Obesity Surgery, 1, 389-395. https://doi.org/10.1381/096089291765560782
[18]
Anderson, K.M., Castelli, W.P. and Levy, D. (1987) Cholesterol and Mortality. JAMA, 257, 2176-2180. https://doi.org/10.1001/jama.1987.03390160062027
[19]
Resende, J.H.C. (2003) Gigantomasty. Plastic Surgery: Fundamentals and Art—Aesthetic Surgery. Medical and Scientific Publisher, Rio de Janeiro, 555-561.
[20]
Resende, J.H.C. (2008) Resende’s Technique for Correcting Gigantomasty—Body Relief Surgery, Treated Plastic Surgery in Obesity. Editora Rubio, Rio de Janeiro, 357-365.
[21]
Resende, J.H.C., de Moura, á.I., Mariano, A.C.A., Silva, H.K., Silva, H.L., Campos, I.A., de Lima, L.C.F., Gabriel, M.B. and Silverio, W.O. (2019) Gigantomasty in Female Workers: “Public Health Cases”. Modern Plastic Surgery, 9, 1-7. https://doi.org/10.4236/mps.2019.91001